National Foundation for Infectious Diseases Announces 2025-2026 Board of Directors

Bethesda, MD (July 9, 2025)—The National Foundation for Infectious Diseases (NFID) is pleased to announce the appointment of Wilbur H. Chen, MD, MS (University of Maryland School of Medicine) and Audrey M. Stevenson, PhD, MPH, FNP-BC (University of Utah School of Medicine), as well as the reappointment of Jean-Venable  R. Goode, PharmD (Virginia Commonwealth University) to the 2025-2026 NFID Board of Directors, for 3-year terms through June 2028.

Wilbur H. Chen, MD, MS, is the Frank M. Calia, MD Endowed Professor of Medicine, chief of the division of geographic medicine, and director of travel medicine practice at the University of Maryland School of Medicine. He is also chief of the adult clinical studies section at the University of Maryland Center for Vaccine Development and Global Health. Médico y científico formado en enfermedades infecciosas en adultos, su carrera ha abarcado el desarrollo y el uso de vacunas para abordar problemas de salud mundiales. He was a voting member of the Advisory Committee on Immunization Practices (ACIP) from 2020-2024. His academic research has focused on vaccines against diarrheal diseases, Campylobacter, Shigella, Cryptosporidium, salmonella, and Clostridioides difficile (C. diff). También tiene una amplia experiencia en investigación clínica sobre vacunas contra la influenza (gripe), la enfermedad meningocócica y agentes de biodefensa, incluidos el ántrax, la viruela, la tularemia y la enterotoxina estafilocócica. Chen ha formado parte del comité de planificación del Curso de Vacunología Clínica de la NFID desde 2019 años y ha sido oradora de la NFID sobre vacunas necesarias para viajar. “I look forward to joining the NFID Board and collaborating with partners to advocate for vaccine programs and improved control and mitigation of diseases through vaccination,” said Chen.

Audrey M. Stevenson, PhD, MPH, FNP-BC, is a faculty member of the graduate nurse practitioner and master of public health programs at the University of Utah School of Medicine and an associate faculty member in the family nurse practitioner program at the University of Phoenix College of Nursing. Enfermera practicante y consultora familiar independiente, ha sido reconocida y premiada por su trabajo en la defensa de las vacunas. Anteriormente fue directora de la división de salud familiar y servicios clínicos del Departamento de Salud del Condado de Salt Lake y formó parte del Comité Asesor de Vacunas de Utah que establece la política estatal de vacunación. Durante la pandemia de COVID-19, dirigió las estrategias de vacunación para 1.2 millones de residentes del condado de Salt Lake. Ahora que se retiró de la práctica clínica, sigue siendo una defensora de las vacunas. Stevenson tiene una maestría en salud pública y enfermería y recibió su doctorado en salud pública de la Universidad de Utah. Se ha desempeñado como oradora en la Conferencia Anual sobre Investigación en Vacunología de la NFID y en el Curso de Vacunología Clínica de la NFID. “NFID is on the cutting-edge of education and awareness,” Stevenson said. “I believe NFID and partners can use our voices to demonstrate the need for continued vigilance on important infectious disease issues, including antimicrobial resistance, vaccine programs, disease monitoring, and the vital education provided to healthcare professionals and the public.”

Jean-Venable (Kelly) R. Goode, PharmD, is professor and director of the Community-Based Pharmacy Residency Program at Virginia Commonwealth University. Es una farmacéutica comunitaria acreditada en Daily Planet Health Services, un centro de salud calificado a nivel federal que brinda servicios a cualquier persona, independientemente de su vivienda o estado de seguro. Desarrolló programas innovadores de atención al paciente farmacéutico dentro de un hogar médico centrado en el paciente, incluido el liderazgo de los programas de Vacunas para Niños y Vacunas para Adultos. Goode is the American Pharmacists Association liaison to ACIP and a former president of the American Pharmacists Association and Virginia Pharmacists Association. “The biggest challenge we face today is vaccine misinformation,” said Goode. “NFID is positioned to address this challenge through community partnerships, education, and consistent messaging to empower pharmacists and other healthcare professionals to engage with patients and address their concerns with evidence-based information, 1 individual at a time.”

The NFID Board of Directors also expresses appreciation to outgoing Director Kathleen H. Harriman, PhD, MPH, RN (California Department of Public Health) for her contributions to NFID.

As the governing body of NFID, the 2025-2026 NFID Board of Directors establishes the NFID strategic direction, ensures that annual goals are met, and provides financial oversight.

Junta Directiva de la NFID 2025-2026

• Kevin A. Ault, MD (NFID Vice President), Western Michigan University Homer Stryker MD School of Medicine
• Oliver T. Brooks, MD, Charles R. Drew University of Medicine and Science
• Wilbur H. Chen, MD, MS, University of Maryland School of Medicine
• Marla Dalton, PE, CAE, NFID CEO (Ex-Officio)
• Monica M. Farley, MD (NFID President-Elect), Emory University School of Medicine
• Jeffery A. Goad, PharmD, MPH (NFID President), Chapman University School of Pharmacy
• Jean-Venable R. Goode, Doctor en Farmacia, Virginia Commonwealth University.
• Robert H. Hopkins, Jr., MD, NFID Medical Director (Ex-Officio)
• Orin S. Levine, PhD, Tin Horse LLC
• Julie Morita, MD, The Joyce Foundation
• Flor M. Muñoz, MD, MSc, Baylor College of Medicine
• Kathleen M. Neuzil, MD, MPH (NFID Federal Liaison)
• Sean T. O'Leary, MD, MPH, Campus Médico Anschutz de la Universidad de Colorado en Denver
• Kevin M. Rooney (NFID Secretary-Treasurer), NervGen Pharma
• Audrey M. Stevenson, PhD, MPH, FNP-BC, University of Utah School of Medicine
• Patricia A. Stinchfield, RN, MS, CPNP (NFID Immediate Past-President)
• Matthew M. Zahn, MD, OC Health Care Agency

Acerca de la National Foundation for Infectious Diseases

Fundada en 1973, National Foundation for Infectious Diseases (NFID) es una organización sin fines de lucro 501(c)(3) dedicada a educar e involucrar al público, las comunidades y los profesionales de la salud sobre las enfermedades infecciosas a lo largo de toda la vida. La NFID tiene una calificación de 4 estrellas de Charity Navigator y ha obtenido un sello platino de transparencia de Candid/GuideStar. Visite www.nfid.org para obtener información adicional.

Contacto: Diana Olson, communications@nfid.org